Polypharmacy and Potentially Inappropriate Prescribing of Benzodiazepines in Older Nursing Home Residents

Overview

Journal Ann Med

Publisher Informa Healthcare

Specialty General Medicine

Date 2024 Jun 4

PMID 38833339

Authors

Ingrid Kummer

Jindra Reissigova

Anna Lukacisinova

Maja Ortner Hadziabdic

Matej Stuhec

Rosa Liperoti

Harriet Finne-Soveri

Graziano Onder

Hein van Hout

Daniela Fialova

Affiliations

Soon will be listed here.

Abstract

Introduction: Previous research has raised concerns about high prevalence of drug-related problems, polypharmacy and inappropriate benzodiazepine prescribing in nursing homes (NHs) and confirmed lack of studies from Central and South-Eastern Europe. The aim of our study was to determine the prevalence and characteristics of polypharmacy, hyperpolypharmacy and inappropriate benzodiazepine prescribing in NH residents in Croatia.

Methods: Data from 226 older NH residents from five Croatian NHs were collected using the InterRAI Long-Term Care Facilities assessment form. The prevalence and determinants of polypharmacy/hyperpolypharmacy and patterns of inappropriate benzodiazepine prescribing were documented.

Results: The prevalence of polypharmacy (49.6%) and hyperpolypharmacy (25.7%) among NH residents was high. In our study, 72.1% of NH residents were prescribed at least one psychotropic agent, 36.7% used 2-3 psychotropics and 6.6% used 4+ psychotropics. Among benzodiazepine users (55.8%), 28% of residents were prescribed benzodiazepines in higher than recommended geriatric doses, 75% used them for the long term and 48% were prescribed concomitant interacting medications. The odds of being prescribed polypharmacy/hyperpolypharmacy were significantly higher for older patients with polymorbidity (6+ disorders, proportional odds ratio (POR) = 19.8), type II diabetes (POR = 5.2), ischemic heart disease (POR = 4.6), higher frailty (Clinical Frailty Scale (CFS ≥5); POR = 4.3) and gastrointestinal problems (POR = 4.8).

Conclusions: Our research underscores the persistent challenge of inappropriate medication use and drug-related harms among older NH residents, despite existing evidence and professional campaigns. Effective regulatory and policy interventions, including the implementation of geriatrician and clinical pharmacy services, are essential to address this critical issue and ensure optimal medication management for vulnerable NH populations.

Citing Articles

Development of the Japanese Anticholinergic Risk Scale: English translation of the Japanese article.

Mizokami F, Mizuno T, Taguchi R, Nasu I, Arai S, Higashi K Geriatr Gerontol Int. 2024; 25(1):5-13.

PMID: 39635941 PMC: 11711069. DOI: 10.1111/ggi.15001.

References

Ostini R, Hegney D, Jackson C, Williamson M, Mackson J, Gurman K . Systematic review of interventions to improve prescribing. Ann Pharmacother. 2009; 43(3):502-13. DOI: 10.1345/aph.1L488. View

OMahony D, OSullivan D, Byrne S, OConnor M, Ryan C, Gallagher P . STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2014; 44(2):213-8. PMC: 4339726. DOI: 10.1093/ageing/afu145. View

Lustenberger I, Schupbach B, von Gunten A, Mosimann U . Psychotropic medication use in Swiss nursing homes. Swiss Med Wkly. 2011; 141:w13254. DOI: 10.4414/smw.2011.13254. View

Spinewine A, Fialova D, Byrne S . The role of the pharmacist in optimizing pharmacotherapy in older people. Drugs Aging. 2012; 29(6):495-510. DOI: 10.2165/11631720-000000000-00000. View

Hanlon J, Semla T, Schmader K . Alternative Medications for Medications in the Use of High-Risk Medications in the Elderly and Potentially Harmful Drug-Disease Interactions in the Elderly Quality Measures. J Am Geriatr Soc. 2015; 63(12):e8-e18. PMC: 4890629. DOI: 10.1111/jgs.13807. View

Simoes P, Miguel Santiago L, Mauricio K, Simoes J . Prevalence Of Potentially Inappropriate Medication In The Older Adult Population Within Primary Care In Portugal: A Nationwide Cross-Sectional Study. Patient Prefer Adherence. 2019; 13:1569-1576. PMC: 6756837. DOI: 10.2147/PPA.S219346. View

Davies L, Spiers G, Kingston A, Todd A, Adamson J, Hanratty B . Adverse Outcomes of Polypharmacy in Older People: Systematic Review of Reviews. J Am Med Dir Assoc. 2020; 21(2):181-187. DOI: 10.1016/j.jamda.2019.10.022. View

Onder G, Liperoti R, Fialova D, Topinkova E, Tosato M, Danese P . Polypharmacy in nursing home in Europe: results from the SHELTER study. J Gerontol A Biol Sci Med Sci. 2012; 67(6):698-704. DOI: 10.1093/gerona/glr233. View

Janhsen K, Roser P, Hoffmann K . The problems of long-term treatment with benzodiazepines and related substances. Dtsch Arztebl Int. 2015; 112(1-2):1-7. PMC: 4318457. DOI: 10.3238/arztebl.2015.0001. View

10.

Harrison S, Bradley C, Milte R, Liu E, Kouladjian Odonnell L, Hilmer S . Psychotropic medications in older people in residential care facilities and associations with quality of life: a cross-sectional study. BMC Geriatr. 2018; 18(1):60. PMC: 6389148. DOI: 10.1186/s12877-018-0752-0. View

11.

Fialova D, Desplenter F . Aging of the Population, Clinical Pharmacy Services, and Interdisciplinary Cooperation in the Optimization of Pharmacotherapy in Older Patients. Drugs Aging. 2016; 33(3):163-7. DOI: 10.1007/s40266-016-0361-6. View

12.

Rockwood K, Song X, MacKnight C, Bergman H, Hogan D, McDowell I . A global clinical measure of fitness and frailty in elderly people. CMAJ. 2005; 173(5):489-95. PMC: 1188185. DOI: 10.1503/cmaj.050051. View

13.

Diez R, Cadenas R, Susperregui J, Sahagun A, Fernandez N, Garcia J . Drug-Related Problems and Polypharmacy in Nursing Home Residents: A Cross-Sectional Study. Int J Environ Res Public Health. 2022; 19(7). PMC: 8998432. DOI: 10.3390/ijerph19074313. View

14.

Baldwin D, Anderson I, Nutt D, Allgulander C, Bandelow B, den Boer J . Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology. J Psychopharmacol. 2014; 28(5):403-39. DOI: 10.1177/0269881114525674. View

15.

Lukacisinova A, Reissigova J, Ortner-Hadziabdic M, Brkic J, Okuyan B, Volmer D . Prevalence, country-specific prescribing patterns and determinants of benzodiazepine use in community-residing older adults in 7 European countries. BMC Geriatr. 2024; 24(1):240. PMC: 10921596. DOI: 10.1186/s12877-024-04742-7. View

16.

Fialova D, Laffon B, Marinkovic V, Tasic L, Doro P, Soos G . Medication use in older patients and age-blind approach: narrative literature review (insufficient evidence on the efficacy and safety of drugs in older age, frequent use of PIMs and polypharmacy, and underuse of highly beneficial nonpharmacological.... Eur J Clin Pharmacol. 2019; 75(4):451-466. DOI: 10.1007/s00228-018-2603-5. View

17.

Maust D, Takamine L, Wiechers I, Blow F, Bohnert A, Strominger J . Strategies Associated With Reducing Benzodiazepine Prescribing to Older Adults: A Mixed Methods Study. Ann Fam Med. 2022; 20(4):328-335. PMC: 9328717. DOI: 10.1370/afm.2825. View

18.

De Souto Barreto P, Lapeyre-Mestre M, Cestac P, Vellas B, Rolland Y . Effects of a geriatric intervention aiming to improve quality care in nursing homes on benzodiazepine use and discontinuation. Br J Clin Pharmacol. 2015; 81(4):759-67. PMC: 4799915. DOI: 10.1111/bcp.12847. View

19.

Maust D, Kales H, Wiechers I, Blow F, Olfson M . No End in Sight: Benzodiazepine Use in Older Adults in the United States. J Am Geriatr Soc. 2016; 64(12):2546-2553. PMC: 5173408. DOI: 10.1111/jgs.14379. View

20.

Stuhec M, Bratovic N, Mrhar A . Impact of clinical pharmacist's interventions on pharmacotherapy management in elderly patients on polypharmacy with mental health problems including quality of life: A prospective non-randomized study. Sci Rep. 2019; 9(1):16856. PMC: 6856189. DOI: 10.1038/s41598-019-53057-w. View